Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,041 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $288.39 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $238.96 | 15 | $0 (2019) |
| Amgen Inc. | $219.17 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $68.35 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $44.01 | 3 | $0 (2017) |
| GE HEALTHCARE | $42.32 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $29.67 | 2 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $22.44 | 1 | $0 (2017) |
| Chiesi USA, Inc. | $22.41 | 1 | $0 (2018) |
| Aegerion Pharmaceuticals, Inc. | $19.33 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $189.80 | 3 | Boston Scientific Corporation ($174.75) |
| 2019 | $54.93 | 2 | GE HEALTHCARE ($42.32) |
| 2018 | $197.82 | 11 | Novartis Pharmaceuticals Corporation ($69.01) |
| 2017 | $598.09 | 28 | Novartis Pharmaceuticals Corporation ($157.34) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $147.50 | General |
| Category: AVVIGO_IC | ||||||
| 02/28/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: General - Pain Management_NMD | ||||||
| 02/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Cardiology | ||||||
| 09/11/2019 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $42.32 | General |
| 01/17/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/26/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/22/2018 | Janssen Pharmaceuticals, Inc | BOSENTAN TABLETS (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Pulmonary Hypertension | ||||||
| 06/08/2018 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Cardiology | ||||||
| 05/10/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE, PRAXBIND | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/19/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/29/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Cardiology | ||||||
| 03/27/2018 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $22.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/20/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardiology | ||||||
| 02/06/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/31/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/16/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $15.77 | General |
| Category: Cardiovascular | ||||||
| 12/15/2017 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiology | ||||||
| 10/27/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/12/2017 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 09/21/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/18/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/03/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE, PRAXBIND | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/16/2017 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: Cardiology | ||||||
| 06/15/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 926 | 1,199 | $373,374 | $69,431 |
| 2022 | 11 | 1,040 | 1,336 | $372,963 | $74,114 |
| 2021 | 10 | 1,215 | 1,591 | $393,183 | $83,395 |
| 2020 | 13 | 1,061 | 1,435 | $364,175 | $75,123 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 289 | 525 | $231,778 | $45,739 | 19.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 125 | 126 | $43,272 | $6,041 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $31,539 | $5,917 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 69 | $21,615 | $4,473 | 20.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 53 | 53 | $15,848 | $2,953 | 18.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 149 | 159 | $11,267 | $1,712 | 15.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 75 | 84 | $8,936 | $1,262 | 14.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 75 | 84 | $5,980 | $865.47 | 14.5% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 18 | 19 | $2,389 | $363.42 | 15.2% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 24 | 25 | $750.00 | $107.10 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 335 | 587 | $246,515 | $51,478 | 20.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $26,064 | $5,773 | 22.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 97 | 100 | $32,742 | $4,870 | 14.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 75 | $22,199 | $4,796 | 21.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 50 | 50 | $13,990 | $2,676 | 19.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 193 | 206 | $14,034 | $1,936 | 13.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 69 | 75 | $7,580 | $1,080 | 14.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2022 | 69 | 75 | $5,085 | $735.10 | 14.5% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2022 | 21 | 21 | $2,514 | $426.40 | 17.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 56 | 67 | $1,280 | $199.50 | 15.6% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 32 | 32 | $960.00 | $142.97 | 14.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 314 | 582 | $221,530 | $52,514 | 23.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 70 | 70 | $38,438 | $8,243 | 21.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 143 | 146 | $49,633 | $7,160 | 14.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 79 | 84 | $22,168 | $5,767 | 26.0% |
About Dr. Bhat Mohan, MD
Dr. Bhat Mohan, MD is a Specialist healthcare provider based in Riverdale, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043219256.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bhat Mohan, MD has received a total of $1,041 in payments from pharmaceutical and medical device companies, with $189.80 received in 2024. These payments were reported across 44 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,041).
As a Medicare-enrolled provider, Mohan has provided services to 4,242 Medicare beneficiaries, totaling 5,561 services with total Medicare billing of $302,063. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Cardiovascular Disease
- Location Riverdale, GA
- Active Since 07/19/2005
- Last Updated 08/05/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1043219256
Products in Payments
- ENTRESTO (Drug) $238.96
- Repatha (Biological) $169.23
- AVVIGO Guidance System (Device) $147.50
- WATCHMAN DEVICE (Device) $113.64
- PRADAXA (Drug) $55.88
- Corlanor (Drug) $49.94
- BRILINTA (Drug) $44.01
- SAMSCA (Drug) $22.44
- CLEVIPREX (Drug) $22.41
- JUXTAPID (Drug) $19.33
- BOSENTAN TABLETS (Drug) $18.58
- Livalo (Drug) $15.77
- PRALUENT ALIROCUMAB INJECTION (Biological) $15.03
- ELIQUIS (Drug) $14.79
- JARDIANCE (Drug) $12.47
- XARELTO (Drug) $11.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Riverdale
Dr. Joseph Saba, M.d, M.D
Specialist — Payments: $5,831
Dr. Kevin Freeman, M.d, M.D
Specialist — Payments: $5,485
Dr. Robert Hsieh, M.d, M.D
Specialist — Payments: $1,479
Mr. Feroze Yusufji, M.d, M.D
Specialist — Payments: $114.78
Dr. Francisco Velez-Reboyras, M.d, M.D
Specialist — Payments: $38.11
Kathryn Clayton, Md, MD
Specialist